Patent 5731338 Issued on March 24, 1998. Estimated Expiration Date: May 2, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
There is disclosed a method for treating a patient suffering from xerostomia, xerophthalmia or excessive intraocular pressure. The method comprises administering to said patient a therapeutically effective amount of pilocarpine, or a pharmaceutically acceptable salt thereof, in an amount sufficient to maintain a blood serum level of pilocarpine in said patient of from about 5 to about 40 ng/ml, for a period of at least 6 hours. Controlled release unit dosage forms containing pilocarpine are also disclosed.
Other References
Schuller et al., "Treatment of radiation side effects with oral pilocarpine" J. Surg. Oncol. (1989) 42:272-276
Severin, "Keatoconjunctivitis sicca " Vet. Clin. North Am. (1973) 3:407-422
Pavan-Langston, "Potential use of ocular-insert therapy in dry eyes" Int. Opthalmol. Clin. (1973) 13:231-238
Deshpande et al., "Sustained release ophthalmic formulations of pilocarpine" J. Pharm. Pharmacol. (1988) 41:197-200
Fox et al., "Pilocarpine treatment of salivary gland hypofunction and dry mouth (Xerostomia)" Arch. Intern. Med. (1991) 151:1149-1152
Fox et al., "Xerostomia: evaluation of a symptom with increasing significance" J. Am. Dent. Assoc, (1985) 110:519-525
Chencharick et al., "Nutritional consequences of the radiotherapy of head and neck cancer" Cancer (1983) 51:811-815
Fox, "Management of salivary gland hypofunction and dry mouth (xerostomia)" Head and Neck Canceer, Fee et al., eds., (1990) pp. 322-324
Fox, "Systemic therapy of salivary gland hypofunction" J. Dent. Res. (1987) 66:689-692
LeVeque et al., "A multicenter, radomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostamia in head and neck cancer patients" J. Clin. Oncol. (1993) 11:1124-1131
Johnson et al., "Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer" N. Engl. J. Med. (1993) 329:390-395
Greenspan et al., "Effectiveness of pilocarpine in postradiation xerostomia" Cancer (1987) 59:1123-1125
Dawes, "The composition of human saliva secreted in response to a gustatory stimulus and to pilocarpine" J. Physiol. (London) (1966) 183:360-368
Mandel et al., "The effect of pharmacologic agents on salivary secretion and composition. II. Isoproterenol, alpha and beta adrenergic blockers" J. Oral. Ther. Pharmacol. (1968) 4:260-269
Fox et al., "Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction" Oral Surg. Oral Med. Oral Pathol. (1986) 61:243-248
Rhodus et al., "Effects of pilocarpine on salivary flow in patients with Sjogren's syndrome" Oral Surg. Oral Med. Oral pathol. (1991) 72:545-549
Greco et al., "Systemic pilocarpine toxicity in the treatment of angle closure glaucoma" Ann. Opthalmol. (1973) 5:57-59
Kastl, "Inadvertent systemic injection of pilocarpine. Case report" Arch. Opthalmol. (1987) 105:28-29
Littmann et al., "Severe symptomatic atrioventricular block induced by pilocarpine eye drops" Arch. Intern. Med. (1987) 147:586-587
Weaver et al., "Pilocarpine disposition and salivary flow responses folowing intravenous administration to dogs" Pharm. Res. (1992) 9:1064-1069
Valdez et al., "Interactions of the salivary and gastrointestinal systems. II Effects of salivary gland dysfunction on the gastrointestinal tract" Dig. Dis. (1991) 9:210-218
Hughes et al., "Oral-pharyngeal dysphagia: A common sequela of salivary gland dysfuntion" Dysphagia (1987) 1:173-177
Caruso et al., "Objective measures of swallowing in patients with primary Sjogren's syndrome" Dysphagia (1989) 4:101-105
Helm, "Role of saliva in esophageal function and disease" Dysphagia (1989) 4:76-84
Korsten et al., "Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury" Am. J. Med. (1991) 90:701-706
Lehr et al., "A surface energy analysis of mucoadhesion: Contact angle measurements on polycarbophil and pig intestinal mucosa in physiologically relevant fluids" Pharm. Res. (1992) 9:70-75
Abstract of Mamtani et al., "Comparison of total costs of administrating calcium polycarbophil and psyllium mucilloid in an institutional setting" Clin. Therap. (1990) 12:22-25
Physician's Desk Reference for Ophthalmology, Walsh, J.B. et al., eds., 16th Edition (1988) pp. 3,1
May 2, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
